MGN1703
Showing 1 - 8 of 8
Advanced Cancers, Melanoma Trial in Houston (MGN1703, Ipilimumab)
Active, not recruiting
- Advanced Cancers
- Melanoma
- MGN1703
- Ipilimumab
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 11, 2022
Small Cell Lung Cancer Trial in Worldwide (MGN1703, Standard of care)
Completed
- Small Cell Lung Cancer
- MGN1703
- Standard of care
-
Innsbruck, Austria
- +3 more
Nov 13, 2018
Treatment Related Cancer Trial in Munich (5-FU, Folinic Acid, Irinotecan)
Active, not recruiting
- Treatment Related Cancer
- 5-FU
- +4 more
-
Munich, GermanyLudwig Maximilians University
Jan 19, 2022
Metastatic Colorectal Cancer Trial in Worldwide (Usual Maintenance, MGN1703 treatment)
Unknown status
- Metastatic Colorectal Cancer
- Usual Maintenance
- MGN1703 treatment
-
Krems, Austria
- +126 more
Sep 9, 2019
HIV Trial in Aarhus N, Hvidovre (MGN1703)
Completed
- HIV
- MGN1703
-
Aarhus N, Denmark
- +1 more
Jun 28, 2017
Healthy Trial in West Bend (MGN-Placebo, Placebo-MGN)
Completed
- Healthy
- MGN-Placebo
- Placebo-MGN
-
West Bend, WisconsinSpaulding Clinical
May 16, 2014
Advanced Colorectal Carcinoma Trial in Worldwide (MGN1703, Placebo)
Completed
- Advanced Colorectal Carcinoma
- MGN1703
- Placebo
-
Wien, Austria
- +11 more
Jun 19, 2014